DoraSet Tablet

Adult dose

Children aged 12 and above and adults should adjust the dose according to the severity of pain and treatment response. Initially administer 2 tablets, ensuring subsequent doses are spaced at least 6 hours apart, and do not exceed 8 tablets per day. The lowest effective dose is to be given for the shortest duration possible. Elderly patients should receive the usual adult dosage, but for those over 75 years of age, administration should be spaced at least 6 hours apart. Moderate renal impairment

Child dose

Pediatric patients aged 12 years and older should receive the same dosage as adults.

This medication can burden the liver, so individuals who consume alcohol in quantities exceeding a certain amount daily must consult a doctor or pharmacist before taking it. If severe rash, itching, blisters, etc. occur during treatment, discontinue use immediately and seek medical attention. Individuals with a risk of seizures should be cautious when taking this medication, as the risk may increase when taken with certain antidepressants or other central nervous system drugs. Patients with severe respiratory diseases may experience difficulty breathing while on this medication, so it should be administered under the supervision of medical personnel. The risk of severe drowsiness or respiratory depression may increase when taken with other central nervous system depressants; hence, caution is needed when used together. Patients with head injuries or brain disorders must consult a doctor before taking this medication as changes in consciousness may occur and caution is required. This medication may lead to dependency, hence care should be taken to avoid prolonged or excessive use. Patients with impaired liver or kidney function must consult a doctor before taking this medication, and dose adjustment may be necessary. It is not recommended for children under 12 years old or adolescents under 18 who have undergone tonsillectomy or adenoidectomy. Pregnant or breastfeeding women should consult a doctor before taking this medication, especially during breastfeeding as it may affect the infant. Drowsiness or dizziness may occur during treatment, so caution is needed when engaging in hazardous activities such as driving or operating machinery. In the event of overdose, serious respiratory depression, seizures, liver damage, etc., may occur, so prescribed dosages must be adhered to and do not increase the dose without medical advice. This medication should be stored out of the reach of children and should be secured to prevent misuse or accidents.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, paleness, severe rash with high fever, blisters, skin peeling, pain in oral/ocular mucous membranes, shortness of breath or difficulty breathing, asthma attacks, respiratory abnormalities accompanied by cough and fever, yellowing of the skin or eyes (jaundice), severe systemic lethargy, sudden and very severe headache, lightning headache, seizures, altered consciousness, visual disturbances, paralysis, urination issues

Mild side effects

• Decreased appetite
• insomnia
• depression
• dizziness
• headache
• drowsiness
• nausea
• vomiting
• constipation
• dry mouth

This medication should be stored in a sealed container to prevent air and moisture exposure, kept in a cool place at room temperature below 25 degrees Celsius. Proper storage will help maintain its effectiveness.

Appearance

Pale yellow rectangular film-coated tablet

Package unit

(For domestic use) 30 tablets/bottle. 300 tablets/bottle (for export) 30 tablets (10 tablets x 3 PTP)